Genetic signatures of ERCC1 and ERCC2 expression, along with SNPs variants, unveil favorable prognosis in SCLC patients undergoing platinum-based chemotherapy
Oncology Research · 2025
DOI: 10.32604/or.2024.050161 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2025. Verfasst von Enrico Caliman und 12 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Oncology Unit, Careggi University Hospital, Florence, 50134, Italy. Hauptthemen laut MEDLINE: Polymorphism, Single Nucleotide, Endonucleases, DNA-Binding Proteins, Xeroderma Pigmentosum Group D Protein. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Oncology Unit, Careggi University Hospital, Florence, 50134, Italy.
- Department of Experimental and Clinical Medicine, University of Florence, Florence, 50134, Italy.
- Department of Health Sciences, University of Florence, Florence, 50134, Italy.
- Medical Oncology Unit, Careggi University Hospital, Florence, 50134, Italy.
- Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, 50134, Italy.
- Section of Anatomic Pathology, Department of Health Sciences, University of Florence, Florence, 50139, Italy.
Zitieren
APA
Caliman, E., Fancelli, S., Scolari, F., Pasqui, A., Manneschi, C., Lavacchi, D., Mazzoni, F., Gensini, F., Pasini, V., Comin, C. E., Voltolini, L., Pillozzi, S., & Antonuzzo, L. (2025). Genetic signatures of ERCC1 and ERCC2 expression, along with SNPs variants, unveil favorable prognosis in SCLC patients undergoing platinum-based chemotherapy. Oncology Research. https://doi.org/10.32604/or.2024.050161
Vancouver
Caliman E, Fancelli S, Scolari F, Pasqui A, Manneschi C, Lavacchi D, et al. Genetic signatures of ERCC1 and ERCC2 expression, along with SNPs variants, unveil favorable prognosis in SCLC patients undergoing platinum-based chemotherapy. Oncology Research. 2025. doi:10.32604/or.2024.050161
BibTeX
@article{Caliman2025,
author = {Caliman, Enrico and Fancelli, Sara and Scolari, Federico and Pasqui, Adriano and Manneschi, Clara and Lavacchi, Daniele and Mazzoni, Francesca and Gensini, Francesca and Pasini, Valeria and Comin, Camilla Eva and Voltolini, Luca and Pillozzi, Serena and Antonuzzo, Lorenzo},
title = {Genetic signatures of ERCC1 and ERCC2 expression, along with SNPs variants, unveil favorable prognosis in SCLC patients undergoing platinum-based chemotherapy},
journal = {Oncology Research},
year = {2025},
doi = {10.32604/or.2024.050161}
}
EUVIMED